Evidence against anandamide as an EDHF mediating the vasodilator action of bradykinin (BK) in the rat heart

被引:0
作者
Quilley, J [1 ]
Fulton, D [1 ]
机构
[1] New York Med Coll, Dept Pharmacol, Valhalla, NY 10595 USA
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
64P
引用
收藏
页码:U51 / U51
页数:1
相关论文
共 4 条
[1]   ROLE OF K+ CHANNELS IN THE VASODILATOR RESPONSE TO BRADYKININ IN THE RAT-HEART [J].
FULTON, D ;
MCGIFF, JC ;
QUILLEY, J .
BRITISH JOURNAL OF PHARMACOLOGY, 1994, 113 (03) :954-958
[2]  
Fulton D, 1996, J PHARMACOL EXP THER, V278, P518
[3]   CYTOCHROME P450-DEPENDENT EFFECTS OF BRADYKININ IN THE RAT-HEART [J].
FULTON, D ;
MAHBOUBI, K ;
MCGIFF, JC ;
QUILLEY, J .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 114 (01) :99-102
[4]   An endogenous cannabinoid as an endothelium-derived vasorelaxant [J].
Randall, MD ;
Alexander, SPH ;
Bennett, T ;
Boyd, EA ;
Fry, JR ;
Gardiner, SM ;
Kemp, PA ;
McCulloch, AI ;
Kendall, DA .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 229 (01) :114-120